Batavia Biosciences, a CDMO specialising in vaccine development, has announced a novel upstream bioprocessing platform aimed at improving polio vaccine production. The innovation, detailed in the journal Vaccine, incorporates fixed-bed bioreactor technology and tangential flow filtration to increase efficiency, lower biosafety
Batavia Biosciences, a contract development and manufacturing organisation (CDMO) specialising in vaccines and viral vectors, has partnered with Vaccine Biotechnology City (VBC) and MEVAC to expand vaccine production in Egypt. The collaboration aims to localise the manufacturing of Measles, Rubella, and Rotavirus vaccines, supporting
Batavia Biosciences, a contract development and manufacturing organisation (CDMO), has announced a strategic partnership with ChromaTan, Inc. The collaboration is focused on the development and integration of BioRMB technology, formerly known as Continuous Countercurrent Tangential Chromatography (CCTC), into Batavia’s AAV
Batavia Biosciences, a contract development and manufacturing organization (CDMO), has announced a partnership with Candel Therapeutics, a clinical stage biopharmaceutical company. The collaboration aims to accelerate the development and production of CAN-3110, an oncolytic viral immunotherapy for glioma brain tumors,
Batavia Biosciences Contract Manufacturing & Development (CDMO) Profile Batavia Biosciences is a science-based CDMO that offers personalized services that fully support all the stages of biopharmaceutical development, from cloning to GMP manufacture and release of clinical material for phase I/II
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
